These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9872639)

  • 1. When an AED meets an ICD... Automated external defibrillator. Implantable cardioverter defibrillator.
    Calle PA; Buylaert W
    Resuscitation; 1998 Sep; 38(3):177-83. PubMed ID: 9872639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-Morning Type Ventricular Fibrillation With J Wave.
    Fujino T; Yamazaki Y; Tsubota T; Ikeda T
    Int Heart J; 2015; 56(4):459-61. PubMed ID: 26084458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated external defibrillation: is survival only a shock away?
    Schwartz B; Verbeek PR
    CMAJ; 2000 Feb; 162(4):533-4. PubMed ID: 10701391
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease.
    Breithardt G; Wichter T; Haverkamp W; Borggrefe M; Block M; Hammel D; Scheld HH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1151-8. PubMed ID: 8160595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

  • 7. Defibrillation for Ventricular Fibrillation: A Shocking Update.
    Nichol G; Sayre MR; Guerra F; Poole J
    J Am Coll Cardiol; 2017 Sep; 70(12):1496-1509. PubMed ID: 28911514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 9. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance and error analysis of automated external defibrillator use in the out-of-hospital setting.
    Macdonald RD; Swanson JM; Mottley JL; Weinstein C
    Ann Emerg Med; 2001 Sep; 38(3):262-7. PubMed ID: 11524645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
    van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing an automated external defibrillator for children at increased risk of sudden arrhythmic death.
    McLeod KA; Fern E; Clements F; McGowan R
    Cardiol Young; 2017 Sep; 27(7):1271-1279. PubMed ID: 28606196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of automated external defibrillator in identifying lethal ventricular arrhythmias.
    Tsuda T; Geary EM; Temple J
    Eur J Pediatr; 2019 Sep; 178(9):1333-1342. PubMed ID: 31297625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in electrical defibrillation.
    Truong JH; Rosen P
    J Emerg Med; 1997; 15(3):331-8. PubMed ID: 9258783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm analysis and charging during chest compressions reduces compression pause time.
    Partridge R; Tan Q; Silver A; Riley M; Geheb F; Raymond R
    Resuscitation; 2015 May; 90():133-7. PubMed ID: 25772540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
    Naccarelli GV
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.